Pharma September 29, 2026 0 Comments

Ind-Ra pegs Pharma FY27 revenue growth at 10% as domestic demand, CDMOs cushion US decline – ETPharma.com

Ind-Ra pegs Pharma FY27 revenue growth at 10% as domestic demand, CDMOs cushion US decline ETPharma.com

Read the full story at source →

Add your Biographical Information. Edit your Profile now.

God of War Laufey preorder details: Editions, bonuses, price and release date explained for PS5 players

Next post

Asian Games 2026 LIVE Day 11: Archers start strong, Anahat Singh's starrer Indian squash team faces Iran

0

Sun Pharma, Aurobindo Pharma, other stocks in focus as Trump exempts India from 100% tariffs on some speci – The Economic Times

0

Nifty Pharma defies mkt slump, up 1% as select drugs exempt from US tariffs – Business Standard

0

US Commerce Dept Exempts Specialty, Rare-Disease Drugs From India From New Tariffs – PGurus

Post Comment Cancel reply